HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes(1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6). HCV NS3 Genotype-3a contains 2 domains which are serine protinase and helicase.
Recombinant Hepatitis C Virus NS3 Genotype-3a produced in E. coli, containing 226 amino acids.
Recombinant Hepatitis C Virus NS3 Genotype-3a is fused to GST tag at its N-terminus and purified by proprietary chromatographic technique.
Sterile Filtered clear solution.
HCV NS3 Genotype-3a solution contains 25mM K2CO3 and 25mM Tris-Base.
Store at 4°C if entire vial will be used within 2-4 weeks.
Store, frozen at -20°C for longer periods of time.
For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).
Avoid multiple freeze-thaw cycles.
Protein is >90% pure as determined by 10% PAGE (coomassie staining).
Lateral flow, ELISA.